P93 Phase II study of epirubicin and docetaxel asneoadjuvant chemotherapy in patients with large breast cancer (stage II-III, tumor size >3.Ocm). Kyushu ET study group in Japan
Titel:
P93 Phase II study of epirubicin and docetaxel asneoadjuvant chemotherapy in patients with large breast cancer (stage II-III, tumor size >3.Ocm). Kyushu ET study group in Japan
Auteur:
Nishimura, R. Raie, Y. Mitsuyama, S. Toyoshima, S. Iwasaki, H. Ichinose, I. Tamura, K. Matsuo, F. Hara, S. Itoyanagi, N.